Upregulation of proinflammatory cytokines in the fetal brain of the Gaucher mouse

被引:37
作者
Bin Hong, Young
Kim, Eun Young
Jung, Sung-Chul
机构
[1] Ewha Womans Univ, Coll Med, Dept Biochem, Seoul 158710, South Korea
[2] Ewha Womans Univ, Natl Inst Hlth, Dept Biomed Sci, Seoul 158710, South Korea
关键词
Gaucher disease; glucosylceramidase; glucocerebrosidase; models; animal; mice; brain; cytokines; nitric oxide;
D O I
10.3346/jkms.2006.21.4.733
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Gaucher disease is caused by a deficiency of glucocerebrosidase. Patients with Gaucher disease are divided into three major phenotypes: chronic nonneuronopathic, acute neuronopathic, and chronic neuronopathic, based on symptoms of the nervous system, the severity of symptoms, and the age of disease onset. The characteristics of patients with acute neuronopathic- and chronic neuronopathic-type Gaucher disease include oculomotor abnormalities, bulbar signs, limb rigidity, seizures and occasional choreoathetoid movements, and neuronal loss. However, the mechanisms leading to the neurodegeneration of this disorder remain unknown. To investigate brain dysfunction in Gaucher disease, we studied the possible role of inflammation in neurodegeneration during development of Gaucher disease in a mouse model. Elevated levels of the proinflammatory cytokines, IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha, were detected in the fetal brains of Gaucher mice. Moreover, the levels of secreted nitric oxide and reactive oxygen species in the brains of Gaucher mice were higher than in wild-type mice. Thus, accumulated glucocerebroside or glucosylsphingosine, caused by glucocerebrosidase deficiency, may mediate brain inflammation in the Gaucher mouse via the elevation of proinflammatory cytokines, nitric oxide, and reactive oxygen species.
引用
收藏
页码:733 / 738
页数:6
相关论文
共 35 条
[1]
Barak V, 1999, EUR CYTOKINE NETW, V10, P205
[2]
Postnatal development of inflammation in a murine model of Niemann-Pick type C disease: immunohistochemical observations of microglia and astroglia [J].
Baudry, M ;
Yao, YQ ;
Simmons, D ;
Liu, JH ;
Bi, XN .
EXPERIMENTAL NEUROLOGY, 2003, 184 (02) :887-903
[3]
Beutler E., 2001, METABOLIC MOL BASES, V3, P3635
[4]
Nitric oxide and the immune response [J].
Bogdan, C .
NATURE IMMUNOLOGY, 2001, 2 (10) :907-916
[5]
THE ROLE OF NEUROGENETICS IN GAUCHER DISEASE [J].
BRADY, RO ;
BARTON, NW ;
GRABOWSKI, GA .
ARCHIVES OF NEUROLOGY, 1993, 50 (11) :1212-1224
[6]
DEMONSTRATION OF A DEFICIENCY OF GLUCOCEREBROSIDE-CLEAVING ENZYME IN GAUCHERS DISEASE [J].
BRADY, RO ;
KANFER, JN ;
BRADLEY, RM ;
SHAPIRO, D .
JOURNAL OF CLINICAL INVESTIGATION, 1966, 45 (07) :1112-&
[7]
DING AH, 1988, J IMMUNOL, V141, P2407
[8]
FABER JL, 1994, ENV HLTH PERSPECTS, V102, P17
[9]
Guzik TJ, 2003, J PHYSIOL PHARMACOL, V54, P469
[10]
Down-regulation of Bcl-2 in the fetal brain of the Gaucher disease mouse model: a possible role in the neuronal loss [J].
Hong, YB ;
Kim, EY ;
Jung, SC .
JOURNAL OF HUMAN GENETICS, 2004, 49 (07) :349-354